DIVOC Health has received an import license from the Central Drugs Standard Control Organisation (CDSCO) for Genedrive 96 SARS-CoV-2 testing kits in India, the startup said in a statement.
It also said that the Genedrive 96 SARS-CoV-2 Kit has been designed by molecular diagnostics Genedrive located in the United Kingdom, and has also received formal approval from the Indian Council of Medical Research (ICMR).
On receiving the approval, Dr Kanav Kahol, founder and CEO, DIVOC Health, said, “We thank the diagnostic division of the Ministry of Health for considering our proposal and allowing us to deliver quality results to the consumers.
The kit is in a ready-to-go solid PCR-bead format that eliminates the need for reagent preparation or cold temperature storage, which makes it a more suitable solution for high-temperature countries such as India.
